Jing Zhou Hou

Dr. Hou is a hematological oncologist and clinical investigator at the UPMC Hillman Cancer Center. As a principal investigator, he has conducted more than 30 clinical trials from phase I to phase III investigating novel targeted, immune modulating agents or combinations with chemotherapy. Dr. Hou serves on the Lymphoma Pathway Committee and was co-chair from 2010-2015 at the ClinicalPath. Dr. Hou received his medical degree from Zhengzhou University and a PhD in Molecular and Cellular Biology from Tulane University. Dr. Hou completed an Internal Medicine residency at the Northeast Ohio Medical University, and a fellowship in Hematology and Medical Oncology at Stanford University.